Literature DB >> 21107602

Detection of Mycoplasma pneumoniae in different respiratory specimens.

Dan Xu1, Shuxian Li, Zhimin Chen, Lizhong Du.   

Abstract

UNLABELLED: Mycoplasma pneumoniae (M. pneumoniae) is an important community-acquired pneumonia pathogen. Serological test and polymerase chain reaction (PCR) assay are the two main laboratory tests to detect M. pneumoniae now. Little information was compared about the sensitivity and specificity of PCR using different specimens including bronchoalveolar lavage (BAL) and nasopharyngeal aspirate (NPA). The aim of the present study was to evaluate diagnostic values of different specimens by fluorescence quantitative real-time PCR and to find clinical features helpful to diagnose M. pneumoniae pneumonia (MPP). Four hundred and six hospitalized pneumonia children were studied. M. pneumoniae DNA in NPA and BAL samples were detected by fluorescence quantitative real-time PCR. M. pneumoniae-specific IgM was tested by ELISA. MPP were diagnosed based on positive M. pneumoniae-specific IgM in 101 (24.9%) children. The median ages of MPP and non-MPP children were 4.1 and 2.4 years, respectively, with significant difference between them (p < 0.001). Laboratory results including leukocyte count, neutrophil percentage, immunoglobulins, except serum IgM, subgroups of T lymphocyte, and BAL cell count had no significant differences in MPP and non-MPP. BAL macrophage cell percentage was lower in BAL-PCR positive children (p = 0.003), while BAL neutrophil percentage was higher in BAL-PCR positive children (p = 0.007). PCR from NPA and BAL were similar in diagnostic parameters, including sensitivity, specificity, PPV, and NPV (78.6%, 63.4%, 39.8%, and 90.6% for NPA-PCR, respectively; 70.3%, 58.7%, 36.0%, and 85.6% for BAL-PCR, respectively).
CONCLUSIONS: NPA is better than BAL as PCR sample in MPP diagnosis for similar performance in PCR assay, cheap, and less invasive. BAL is useful in defining local inflammatory condition. Age is the only prefigurative factor in MPP.

Entities:  

Mesh:

Year:  2010        PMID: 21107602     DOI: 10.1007/s00431-010-1360-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  35 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks.

Authors:  Kathleen A Thurman; Nicholas D Walter; Stephanie B Schwartz; Stephanie L Mitchell; Michael T Dillon; Andrew L Baughman; Meredith Deutscher; John P Fulton; Jon E Tongren; Lauri A Hicks; Jonas M Winchell
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

3.  Clinical use of capillary PCR to diagnose Mycoplasma pneumonia.

Authors:  J Honda; T Yano; M Kusaba; J Yonemitsu; H Kitajima; M Masuoka; K Hamada; K Oizumi
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 4.  Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.

Authors:  Mitsuo Narita
Journal:  J Infect Chemother       Date:  2010-02-27       Impact factor: 2.211

Review 5.  Laboratory diagnosis of Mycoplasma pneumoniae infection.

Authors:  F Daxboeck; R Krause; C Wenisch
Journal:  Clin Microbiol Infect       Date:  2003-04       Impact factor: 8.067

Review 6.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 7.  Pediatric respiratory infections by Mycoplasma pneumoniae.

Authors:  Kyung-Yil Lee
Journal:  Expert Rev Anti Infect Ther       Date:  2008-08       Impact factor: 5.091

8.  Three familial cases of drug-resistant Mycoplasma pneumoniae infection.

Authors:  Shintaro Kamizono; Hitomi Ohya; Sadanobu Higuchi; Norio Okazaki; Mitsuo Narita
Journal:  Eur J Pediatr       Date:  2009-11-08       Impact factor: 3.183

9.  Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003.

Authors:  Jinho Yu; Young Yoo; Do Kyun Kim; Hee Kang; Young Yull Koh
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

10.  Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection.

Authors:  Anna C Nilsson; Per Björkman; Kenneth Persson
Journal:  BMC Microbiol       Date:  2008-06-11       Impact factor: 3.605

View more
  19 in total

1.  Reply to "how to diagnose Mycoplasma pneumoniae etiology in a child with pneumonia".

Authors:  Dan Xu; Shuxian Li; Zhimin Chen; Lizhong Du
Journal:  Eur J Pediatr       Date:  2011-10-07       Impact factor: 3.183

2.  How to diagnose Mycoplasma pneumoniae etiology in a child with pneumonia?

Authors:  Matti Korppi
Journal:  Eur J Pediatr       Date:  2011-07-20       Impact factor: 3.183

Review 3.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Comparison of enzyme-linked immunosorbent assay with indirect immunofluorescence assay for the diagnosis of Mycoplasma pneumoniae infection.

Authors:  Chun-Hai Gao; Bao-Ju Ji; Chao Han; Mao-Shui Wang
Journal:  J Clin Lab Anal       Date:  2018-09-17       Impact factor: 2.352

5.  Epidemiological characteristics and meteorological factors of childhood Mycoplasma pneumoniae pneumonia in Hangzhou.

Authors:  Ying-Chun Xu; Lan-Juan Zhu; Dan Xu; Xiao-Fen Tao; Shu-Xian Li; Lan-Fang Tang; Zhi-Min Chen
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

6.  Rapid Detection of the Macrolide Sensitivity of Pneumonia-Causing Mycoplasma pneumoniae Using Quenching Probe Polymerase Chain Reaction (GENECUBE®).

Authors:  Yutaka Ito; Satoru Iwashima; Satoshi Hayano; Tomohiro Nishio; Ryosuke Shiozawa; Soichiro Yata; Toshiko Kubota; Akira Kubota; Keiichi Uemura
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

7.  Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay.

Authors:  Wei Li; Yujie Liu; Yun Zhao; Ran Tao; Yonggang Li; Shiqiang Shang
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

8.  Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia.

Authors:  Zhengrong Chen; Xuejun Shao; Xunwu Dou; Xinxing Zhang; Yuqing Wang; Canhong Zhu; Chuangli Hao; Mingyue Fan; Wei Ji; Yongdong Yan
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  Increased concentrations of soluble B7-H3 and interleukin 36 in bronchoalveolar lavage fluid of Children with Mycoplasma pneumoniae pneumonia.

Authors:  Zhengrong Chen; Xin Zhao; Xinxing Zhang; Guangbo Zhang; Huiming Sun; Wujun Jiang; Yuqing Wang; Canhong Zhu; Wei Ji; Yongdong Yan
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

10.  Impact of Epstein-Barr virus coinfection in Mycoplasma pneumoniae pneumonia.

Authors:  Yingchun Xu; Shuxian Li; Jinling Liu; Junfen Zhou; Fang Jin; Xiaoyang Chen; Yingshuo Wang; Yuan Jiang; Zhimin Chen
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.